12.21
price up icon0.62%   0.075
after-market Dopo l'orario di chiusura: 12.24 0.03 +0.25%
loading

Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
12.08%
70.01
62.47 67.77 57.19 50.30
Cost Of Revenue
17.02%
7.115
8.574 6.035 8.909 7.752
Gross Profit
16.70%
62.89
53.89 61.74 48.28 42.55
Operating Expenses
33.60%
42.81
32.04 49.99 49.80 55.80
Benefits Costs and Expenses
25.54%
47.85
38.12 52.96 55.71 60.31
Costs And Expenses
22.91%
49.92
40.62 56.02 58.70 63.56
Operating Income/Loss
8.07%
20.08
21.85 11.75 -1.513 -13.25
Income/Loss From Continuing Operations Before Tax
9.01%
22.16
24.35 14.81 1.478 -10.01
Income Tax Expense/Benefit
36.02%
0.643
1.005 0.457 0.756 0.739
Income/Loss From Continuing Operations After Tax
7.84%
21.51
23.34 14.35 0.722 -10.75
Net Income/Loss
7.84%
21.51
23.34 14.35 0.722 -10.75
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2.91%
134.87
138.92 143.05 143.33 144.01
Diluted Average Shares
3.96%
137.53
143.20 145.65 144.11 144.01
Basic Earnings Per Share
5.88%
0.16
0.17 0.10 0.01 -0.07
Diluted Earnings Per Share
0.00%
0.16
0.16 0.10 0.01 -0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Capitalizzazione:     |  Volume (24 ore):